Rakesh Gulati, MD
Nephrology · Philadelphia, PANPI 1770571937
Payments from drug & device makers
Across 746 payments — averaging $884.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$437K
- Bayer$70K
- Johnson & Johnson$46K
- Travere Therapeutics, Inc.$39K
- Otsuka America Pharmaceutical, Inc.$27K
- Aurinia Pharma U.S., Inc.$17K
- plus $23K from 13 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 510 | $436,682 |
| Bayer | 57 | $70,476 |
| Johnson & Johnson | 50 | $45,635 |
| Travere Therapeutics, Inc. | 57 | $39,442 |
| Otsuka America Pharmaceutical, Inc. | 19 | $26,859 |
| Aurinia Pharma U.S., Inc. | 20 | $17,191 |
| Veloxis Pharmaceuticals, Inc. | 1 | $6,325 |
| Calliditas Therapeutics US Inc. | 6 | $4,627 |
| Janssen Research & Development, LLC | 1 | $2,964 |
| Sobi, Inc | 3 | $2,354 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 7 | $2,337 |
| Vifor Pharma, Inc. | 1 | $2,100 |
| Amgen | 3 | $2,041 |
| Medtronic | 2 | $217 |
| Novartis | 3 | $144 |
| GSK | 1 | $120 |
| Lilly USA, LLC | 1 | $108 |
| Nxstage Medical, Inc. | 3 | $63 |
| Apellis Pharmaceuticals, Inc. | 1 | $22 |
How this compares
$659,707 in reported general payments places this provider in the 95th percentile of 586 nephrology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Philadelphia
- Katalin SusztakPhiladelphia$4.8M
- Debbie Cohen SteinPhiladelphia$2.8M
- Iris LeePhiladelphia$1.9M
- Abdallahsassine GearaPhiladelphia$1.2M
- Gaia MuallemPhiladelphia$942K
- Roy BloomPhiladelphia$575K
- Jonathan HoganPhiladelphia$551K
- Laura DemberPhiladelphia$550K
- Kwabena NtosoPhiladelphia$482K
- Raymond TownsendPhiladelphia$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.